- Home
- PFE
PFE
Pfizer Inc.
as 08-08-2025 10:40am EST
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
| Founded: | 1849 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 134.2B | IPO Year: | N/A |
| Target Price: | $29.75 | AVG Volume (30 days): | 46.5M |
| Analyst Decision: | Hold | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $20.91 - $30.43 | Next Earning Date: | 08-05-2025 |
| Revenue: | $63,833,000,000 | Revenue Growth: | 13.53% |
| Revenue Growth (this year): | -0.7% | Revenue Growth (next year): | -0.66% |
Latest Pfizer Inc. News
PFE Breaking Stock News: Dive into PFE Ticker-Specific Updates for Smart Investing
MT Newswires
3 hours ago
GSK to Receive $370 Million From CureVac, BioNTech Patent Dispute Settlement
The Wall Street Journal
7 hours ago
GSK to Receive $370 Million in U.S. Patent Litigation Settlement
Insider Monkey
11 hours ago
Pfizer (PFE) Releases Financial Results for Q2 2025
Morningstar Research
17 hours ago
Analyst Report: Viatris Inc.
Barrons.com
21 hours ago
Healthcare Stocks Have Been Beaten Up. The Case for Buying Now.
GlobeNewswire
a day ago
Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
GlobeNewswire
a day ago
United States Vaccines Market Insights and Forecasts 2024 & 2025-2033 | Rising Infectious Disease Burden, Robust Funding and Regulatory Support Accelerate Innovation
GlobeNewswire
a day ago
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
Compare PFE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PFE Pfizer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.